Loading clinical trials...
Loading clinical trials...
A Phase 1/2 Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma
Conditions
Interventions
Carfilzomib
Dexamethasone
Locations
35
United States
Arizona Oncology Associates
Tucson, Arizona, United States
Comprehensive Blood and Cancer Center (CCBC)
Bakersfield, California, United States
California Cancer Associates for Research and Excellence
Encinitas, California, United States
Robert A. Moss, M.D., FACP, Inc.
Fountain Valley, California, United States
California Cancer Associates for Research and Excellence
Fresno, California, United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
Start Date
July 4, 2012
Primary Completion Date
July 22, 2016
Completion Date
October 31, 2018
Last Updated
September 23, 2022
NCT06152575
NCT06179888
NCT04973605
NCT05201781
NCT05862012
NCT06138275
Lead Sponsor
Amgen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions